Cargando…

SARS-CoV-2-associated gastrointestinal and liver diseases: what is known and what is needed to explore

BACKGROUND: The pandemic of COVID19 which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first described in China as an unexplained pneumonia transmitted by respiratory droplets. Gastrointestinal (GI) and liver injury associated with SARS-CoV-2 infection were reported...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sweed, Dina, Abdelsameea, Eman, Khalifa, Esraa A., Abdallah, Heba, Moaz, Heba, Moaz, Inas, Abdelsattar, Shimaa, Abdel-Rahman, Nadine, Mosbeh, Asmaa, Elmahdy, Hussein A., Sweed, Eman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325538/ https://www.ncbi.nlm.nih.gov/pubmed/34777871 http://dx.doi.org/10.1186/s43066-021-00123-6

Ejemplares similares

The clinicopathological and prognostic factors of hepatocellular carcinoma: a 10-year tertiary center experience in Egypt
por: Sweed, Dina, et al.
Publicado: (2022)

Trichrome-positive intrahepatic cytoplasmic globules are potential histopathological clue for COVID-19-induced hepatitis: a case report
por: Sweed, Dina, et al.
Publicado: (2021)

Post direct acting anti-viral agents associated primary hepatic Castleman's disease: A case report
por: Sweed, Dina, et al.
Publicado: (2020)

Role of liver biopsy in management of liver diseases without hepatic nodules following end of the interferon era: experience of a tertiary referral center
por: Ehsan, Nermine A., et al.
Publicado: (2022)

The Potential Utility of Circulating Oncofetal H19 Derived miR-675 Expression versus Tissue lncRNA-H19 Expression in Diagnosis and Prognosis of HCC in Egyptian Patients
por: Abdelsattar, Shimaa, et al.
Publicado: (2022)

Activation of angiotensin-converting enzyme 2 ameliorates metabolic syndrome-induced renal damage in rats by renal TLR4 and nuclear transcription factor κB downregulation
por: El-Domiaty, Heba F., et al.
Publicado: (2022)

Evaluation of Amino Acids Profile as Non-Invasive Biomarkers of Hepatocellular Carcinoma in Egyptians
por: Ghanem, Samar Ebrahim, et al.
Publicado: (2022)

The Influence of Smoking on Renal Functions Among Apparently Healthy Smokers
por: Eid, Hoda A, et al.
Publicado: (2022)

Utilization Behavior: What Is Known and What Has to Be Known?
por: Iaccarino, Leonardo, et al.
Publicado: (2014)

The Prognostic Role of CD73/A2AR Expression and Tumor Immune Response in Periampullary Carcinoma Subtypes
por: Sweed, Dina, et al.
Publicado: (2022)

"Sinopharm", "Oxford-AstraZeneca", and "Pfizer-BioNTech" COVID-19 vaccinations: testing efficacy using lung CT-volumetry with comparative analysis of variance (ANOVA)
por: Samir, Ahmed, et al.
Publicado: (2023)

Sitagliptin Attenuates the Cognitive Deficits in L-Methionine-Induced Vascular Dementia in Rats
por: Khodir, Suzan A., et al.
Publicado: (2022)

Coronavirus Disease 2019 in Neonates – What Is Known and What Needs to Be Known
por: Nayak, Manas, et al.
Publicado: (2020)

Evaluating the safety and efficacy of the leukotriene receptor antagonist montelukast as adjuvant therapy in obese patients with type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trial
por: El-Khateeb, Eman, et al.
Publicado: (2023)

Question what is “known”
por: Heller, H. Craig
Publicado: (2021)

Antipsychotics cardiotoxicity: What's known and what's next
por: Li, Xiao-Qing, et al.
Publicado: (2021)

Chemokine receptor CXCR6 gene polymorphism and treatment response of chronic hepatitis C virus in Egyptian patients
por: Hassona, Mona M, et al.
Publicado: (2021)

Study of the association between a MICA gene polymorphism and cholangiocarcinoma in Egyptian patients
por: Abdel-Rahman, Adel A.-H., et al.
Publicado: (2022)

Pediatric Hepatocellular Adenomas: What Is Known and What Is New?
por: Espinoza, Andres F., et al.
Publicado: (2023)

Pathogenesis of multimorbidity—what is known?
por: Wetterling, Tilman
Publicado: (2020)

Stroke and Etiopathogenesis: What Is Known?
por: Ciarambino, Tiziana, et al.
Publicado: (2022)

The Putative Role of Natural Killer Cells in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma
por: Hassona, Mona M, et al.
Publicado: (2021)

A stepwise multi-disciplinary algorithm for diagnosis of fibrosing lung diseases contributing MDCT, MRI, and PET/CT: a study on 250 patients using significance and validation analyses
por: Samir, Ahmed, et al.
Publicado: (2022)

Fungus under a Changing Climate: Modeling the Current and Future Global Distribution of Fusarium oxysporum Using Geographical Information System Data
por: Alkhalifah, Dalal Hussien M., et al.
Publicado: (2023)

Management of ARDS – What Works and What Does Not
por: Banavasi, Harsha, et al.
Publicado: (2021)

Ion Channels in Inflammatory Processes: What Is Known and What Is Next?
por: Retamal, Mauricio A., et al.
Publicado: (2016)

Hyperglycemia and COVID-19: What was known and what is really new?
por: Ceriello, Antonio
Publicado: (2020)

Circulating Biomarkers in Neuromuscular Disorders: What Is Known, What Is New
por: Barp, Andrea, et al.
Publicado: (2021)

Immune checkpoint inhibitor-related pancreatitis: What is known and what is not
por: Jiang, Chunyan, et al.
Publicado: (2023)

Long COVID: what is known and what gaps need to be addressed
por: Krishna, Benjamin, et al.
Publicado: (2023)

The Infectious Pancreatic Necrosis Virus (IPNV) and its Virulence Determinants: What is Known and What Should be Known
por: Dopazo, Carlos P.
Publicado: (2020)

Splenomegaly versus pathological lung volume during COVID-19 infection with or without cytokine storm; a linear regression analysis using CT volumetry
por: Samir, Ahmed, et al.
Publicado: (2022)

Intravesical bacillus Calmette-Guerin for bladder cancer: What is known? What is not? What is next?
por: Madbouly, Khaled
Publicado: (2013)

Platelet-albumin-bilirubin score - a predictor of outcome of acute variceal bleeding in patients with cirrhosis
por: Elshaarawy, Omar, et al.
Publicado: (2020)

Treatment of Extracranial Carotid Artery Aneurysms: What is Known and What is Unknown?
por: de Borst, G.J., et al.
Publicado: (2017)

Pathological Mechanisms in Diabetes of the Exocrine Pancreas: What’s Known and What’s to Know
por: Wei, Qiong, et al.
Publicado: (2020)

Laryngopharyngeal reflux concept: what is known and what should we focus on?()
por: Sirin, Seher, et al.
Publicado: (2019)

Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future?
por: Cazzaniga, Marina Elena, et al.
Publicado: (2019)

Diaphragmatic motor cortex hyperexcitability in patients with chronic obstructive pulmonary disease
por: Elnemr, Rehab, et al.
Publicado: (2019)

Augmented Renal Clearance: What Have We Known and What Will We Do?
por: Luo, Yifan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1eisn1jbu4es30ss1iiok91qcc